Search results for "Gel"

showing 10 items of 3561 documents

The ethnobotany, phytochemistry, and biological properties of Nigella damascena – A review

2022

This review is a systematic scientific work on medicinal and traditional use, on the chemical composition of specialized metabolites, volatile and non-volatile, on aspects related to toxicology and phytotherapy of Nigella damascena L. The genus Nigella (Ranunculaceae) is distributed throughout the Mediterranean basin, extending to northern India, and has been divided into three sections. Nigella damanscena L. is traditionally used as an ingredient in food, for example, as flavouring agents in bread and cheese, but is also known in folk medicine, used to regulate menstruation; for catarrhal affections and amenorrhea; as a diuretic and sternutatory; as an analgesic, anti-oedematous, and antip…

Dolabellane diterpenesAntipyreticsβ-elemenePlant ExtractsPhytochemicalsEthnobotanyPlant ScienceGeneral MedicineSettore CHIM/06 - Chimica OrganicaHorticultureAnticancer propertiesBiochemistryNigella damascenaAnti-inflammatory aspectsFixed oilsEthnopharmacologySettore BIO/03 - Botanica Ambientale E ApplicataMedicine TraditionalSettore BIO/15 - Biologia FarmaceuticaMolecular BiologyRanunculaceaePhytotherapy
researchProduct

Algorithmic approaches to Siegel's fundamental domain

2017

Siegel determined a fundamental domain using the Minkowski reduction of quadratic forms. He gave all the details concerning this domain for genus 1. It is the determination of the Minkowski fundamental domain presented as the second condition and the maximal height condition, presented as the third condition, which prevents the exact determination of this domain for the general case. The latest results were obtained by Gottschling for the genus 2 in 1959. It has since remained unexplored and poorly understood, in particular the different regions of Minkowski reduction. In order to identify Siegel's fundamental domain for genus 3, we present some results concerning the third condition of thi…

Domaine fondamental de SiegelMinkowski ‘s reductionSiegel’s fundamental domain[MATH.MATH-GM] Mathematics [math]/General Mathematics [math.GM]Réduction de MinkowskiTheta functionsFonctions thêta
researchProduct

Long-Circulating Hyaluronan-Based Nanohydrogels as Carriers of Hydrophobic Drugs

2018

[EN] Nanohydrogels based on natural polymers, such as polysaccharides, are gaining interest as vehicles for therapeutic agents, as they can modify the pharmacokinetics and pharmacodynamics of the carried drugs. In this work, hyaluronan-riboflavin nanohydrogels were tested in vivo in healthy rats highlighting their lack of toxicity, even at high doses, and their different biodistribution with respect to that of native hyaluronan. They were also exploited as carriers of a hydrophobic model drug, the anti-inflammatory piroxicam, that was physically embedded within the nanohydrogels by an autoclave treatment. The nanoformulation was tested by intravenous administration showing an improvement of…

DrugBiodistributionmedia_common.quotation_subjectRiboflavinPharmaceutical Sciencelcsh:RS1-441Pharmacokinetic02 engineering and technologyPharmacologyPiroxicam030226 pharmacology & pharmacyArticleNanohydrogelsLong circulatinglcsh:Pharmacy and materia medica03 medical and health sciencesPiroxicam0302 clinical medicineBiodistributionPharmacokineticsIn vivomedicineHyaluronanbiodistribution; hyaluronan; hydrophobic drugs; nanohydrogels; pharmacokinetic; piroxicam; riboflavinmedia_commonChemistry021001 nanoscience & nanotechnologyHydrophobic drugsToxicityCirculation time0210 nano-technologymedicine.drug
researchProduct

Antibacterial drug release from a biphasic gel system: Mathematical modelling

2019

Bacterial infections represent an important drawback in the orthopaedic field, as they can develop either immediately after surgery procedures or after some years. Specifically, in case of implants, they are alleged to be troublesome as their elimination often compels a surgical removal of the infected implant. A possible solution strategy could involve a local coating of the implant by an antibacterial system, which requires to be easily applicable, biocompatible and able to provide the desired release kinetics for the selected antibacterial drug. Thus, this work focusses on a biphasic system made up by a thermo-reversible gel matrix (Poloxamer 407/water system) hosting a dispersed phase (…

DrugMaterials sciencemedia_common.quotation_subjectVancomycin HydrochloridePharmaceutical SciencePoloxamer02 engineering and technologyantibacterial drugengineering.material030226 pharmacology & pharmacyDiffusion03 medical and health scienceschemistry.chemical_compoundDrug Delivery Systems0302 clinical medicineMicro-particleCoatingVancomycinAntibacterial drugmedicineAntibacterial drugmedia_commonGelMathematical modellingReproducibility of ResultsMicro-particlesModels Theoretical021001 nanoscience & nanotechnologyAnti-Bacterial AgentsDrug LiberationKineticsPLGAchemistrySettore CHIM/09 - Farmaceutico Tecnologico Applicativoantibacterial drug; Gels; Mathematical modelling; Micro-particles; Orthopaedic implantsPoloxamer 407engineeringOrthopaedic implantsDelivery systemImplant0210 nano-technologyGelsmedicine.drugBiomedical engineeringInternational Journal of Pharmaceutics
researchProduct

Functionalized Poly(N-isopropylacrylamide)-Based Microgels in Tumor Targeting and Drug Delivery

2021

Over the past several decades, the development of engineered small particles as targeted and drug delivery systems (TDDS) has received great attention thanks to the possibility to overcome the limitations of classical cancer chemotherapy, including targeting incapability, nonspecific action and, consequently, systemic toxicity. Thus, this research aims at using a novel design of Poly(N-isopropylacrylamide) p(NIPAM)-based microgels to specifically target cancer cells and avoid the healthy ones, which is expected to decrease or eliminate the side effects of chemotherapeutic drugs. Smart NIPAM-based microgels were functionalized with acrylic acid and coupled to folic acid (FA), targeting the f…

DrugPolymers and PlasticsBiocompatibilitySciencemedia_common.quotation_subjectp(NIPAM)-co-5%AA microgelsGeneral. Including alchemyBioengineeringdoxorubicinArticleP(NIPAM)-co-5% microgelsBiomaterialschemistry.chemical_compoundfolic acidQD1-65Settore BIO/10 - BiochimicamedicinecancerDoxorubicinViability assayQD1-999QD146-197media_commonQOrganic ChemistryCancermedicine.diseaseChemistrychemistryDrug deliveryCancer cellPoly(N-isopropylacrylamide)BiophysicsInorganic chemistrymedicine.drugGels
researchProduct

Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse …

2015

The treatment of various hair disorders has become a central focus of good dermatologic patient care as it affects men and women all over the world. For many inflammatory-based scalp diseases, glucocorticoids are an essential part of treatment, even though they are known to cause systemic as well as local adverse effects when applied topically. Therefore, efficient targeting and avoidance of these side effects are of utmost importance. Optimizing the balance between drug release, interfollicular permeation, and follicular uptake may allow minimizing these adverse events and simultaneously improve drug delivery, given that one succeeds in targeting a sustained release formulation to the hair…

DrugSwinePolyestersmedia_common.quotation_subjectAnti-Inflammatory AgentsPharmaceutical Science02 engineering and technologyPharmacologyNanocapsules030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineNanocapsulesPhysical StimulationmedicineAnimalsHumansmedia_commonTransdermalActive ingredientClobetasolintegumentary systemChemistryHydrogels021001 nanoscience & nanotechnologyHair follicleDrug Liberationmedicine.anatomical_structureDrug deliveryClobetasol propionateNanocarriers0210 nano-technologyHair Folliclemedicine.drug
researchProduct

Solid and Semisolid Innovative Formulations Containing Miconazole-Loaded Solid Lipid Microparticles to Promote Drug Entrapment into the Buccal Mucosa

2021

The currently available antifungal therapy for oral candidiasis (OC) has various limita- tions restricting its clinical use, such as short retention time, suboptimal drug concentration and low patients compliance. These issues could be overcome using micro or nanotechnology. In par- ticular, solid lipid microparticles (SLMs) resulted as a particularly promising penetration enhancer carrier for lipophilic drugs, such as the antifungal miconazole (MCZ). Based on these considera- tions, cetyl decanoate (here synthesized without the use of metal catalysis) was employed together with 1-hexadecanol to prepare MCZ-loaded SLMs. These resulted in a powder composed of 45–300 µm diameter solid spheric…

Drugbuccal filmmedia_common.quotation_subjectPharmaceutical SciencemiconazoleBuccal mucosaArticleDosage formbuccal gelEntrapmentPharmacy and materia medicaoral candidiasismedicineex vivo studiemedia_commonChromatographycetyl decanoateChemistryex vivo studiesBuccal administrationPermeationoral candidiasiRS1-441mucosal deliverySettore CHIM/09 - Farmaceutico Tecnologico Applicativopenetration enhancersolid lipid microparticlebuccal mucosasolid lipid microparticlesMiconazoleEx vivomedicine.drugPharmaceutics
researchProduct

Injectable in situ forming microgels of hyaluronic acid-g-polylactic acid for methylprednisolone release

2013

Abstract A hydrophobic derivative of hyaluronic acid (HA), obtained by grafting polylactic acid (PLA) to the polysaccharide, has been exploited to produce injectable in situ forming microgels. First of all, self assembling properties of HA-g-PLA copolymer have been evaluated by determining the critical aggregation concentration (CAC) value, then this copolymer has been dissolved in a mixture water/NMP 5:2 v/v with a concentration greater than CAC. When solutions at 1% or 2% w/v were injected into Dulbecco phosphate buffer solution (DPBS) pH 7.4, microgels promptly are formed. Their stability in DPBS pH 7.4 in the absence or in the presence of hyaluronidase and cell compatibility have been e…

Drugchemistry.chemical_classificationMaterials sciencePolymers and Plasticsmedia_common.quotation_subjectOrganic ChemistryGeneral Physics and Astronomymicrogels hyaluronic acid methylprednisolone drug delivery systemGraftingPolysaccharidechemistry.chemical_compoundPolylactic acidchemistryMethylprednisoloneHyaluronidaseSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoPolymer chemistryHyaluronic acidMaterials ChemistrymedicineCopolymermedicine.drugmedia_commonNuclear chemistry
researchProduct

Microseparation techniques for the study of the enantioselectivity of drug-plasma protein binding.

2009

Stereoselectivity in protein binding can have a significant effect on the pharmacokinetic and pharmacodynamic properties of chiral drugs. The investigation of enantioselectivity of drugs in their binding with human plasma proteins and the identification of the molecular mechanisms involved in the stereodiscrimination by the proteins represent a great challenge for clinical pharmacology. In this review, the separation techniques used for enantioselective protein binding experiments are described and compared. An overview of studies on enantiomer–protein interactions, enantiomer–enantiomer interactions as well as chiral drug–drug interactions, including allosteric effects, is presented. The c…

Drugmedia_common.quotation_subjectClinical BiochemistryAllosteric regulationPlasma protein bindingBiochemistryChromatography AffinityAnalytical ChemistryPharmacokineticsSpecies SpecificityDrug DiscoveryHumansAnimal speciesMolecular Biologymedia_commonPharmacologyChromatographyChemistryEnantioselective synthesisElectrophoresis CapillaryStereoisomerismGeneral MedicineBlood ProteinsBlood proteinsPharmaceutical PreparationsChromatography GelStereoselectivityAllosteric SiteProtein BindingBiomedical chromatography : BMC
researchProduct

Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns.

1990

A major cytoskeletal polypeptide (Mr approximately 46,000; protein IT) of human intestinal epithelium was characterized by biochemical and immunological methods. The polypeptide, which was identified as a specific and genuine mRNA product by translation in vitro, reacted, in immunoblotting after SDS-PAGE, only with one of numerous cytokeratin (CK) antisera tested but with none of many monoclonal CK antibodies. In vitro, it formed heterotypic complexes with the type II CK 8, as shown by blot binding assays and gel electrophoresis in 4 M urea, and these complexes assembled into intermediate filaments (IFs) under appropriate conditions. A chymotrypsin-resistant Mr approximately 38,000 core fra…

DuodenumImmunoblottingMolecular Sequence DataBiologyPeptide MappingEpitheliumCytokeratinIntestinal mucosaSequence Homology Nucleic AcidKeratinProtein biosynthesisAnimalsHumansElectrophoresis Gel Two-DimensionalAmino Acid SequenceRNA MessengerIntestinal MucosaIntermediate filamentCytoskeletonPeptide sequenceCytoskeletonchemistry.chemical_classificationArticlesCell BiologyMolecular biologyRatsBlotCytoskeletal ProteinsMicroscopy ElectronBiochemistrychemistryProtein BiosynthesisKeratinsJournal of Cell Biology
researchProduct